Millipore Sigma Webinar
 

Co-operation agreement between artus and the Bernhard-Nocht-Institute for Tropical Medicine

artus GmbH (Hamburg) and the Bernhard-Nocht-Institute for Tropical Medicine (BNI, Hamburg) have announced that they will co- operate on the development and marketing of diagnostic PCR kits.

The BNI will develop a variety of PCR-kits for the detection of pathogens that will be marketed worldwide together with artus.

'This co-operation increases our research and development capacity in the area of tropical pathogens considerably and makes it possible for the BNI to commercialize their know-how' says Thomas Grewing, Head of Research & Development at artus.

The first project will be the development of a detection system for Ebola viruses. This allows artus to supplement its existing range of products for the detection of tropical disease pathogens, e.g. Dengue and West-Nile Virus.

As National Reference Center for Tropical Diseases, the BNI possesses a broad range of specialized diagnostic techniques and is running a laboratory of the highest biological safety category for handling extremely contagious fever viruses.


NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source : artus GmbH [Germany]
Now part of QIAGEN Benelux B.V. View Company Information

Posted on February 3, 2003



Fijifilm Pyrostar testing critical water used in the reprocessing of medical devices
 

SGL Plates and Culture Media for Pharmaceutical Microbiology
 

AI for microbiology
 

QC Standards Controls and Proficiency Testing Schemes
 

Get our eNewsletter
Over 7,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!

LATEST MICROBIOLOGY NEWS

MICROBIOLOGY EVENTS